MURPHY ANDREW J has filed 87 insider transactions across 1 company since May 2023.
Most recent transaction: a tax payment of 4229 shares of REGENERON PHARMACEUTICALS, INC. ($REGN) on December 09, 2025.
Activity breakdown: 0 open-market purchases and 55 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 4229 | $701.51 | 52,208.0000 | 136,200,000 | 7.49% | 0.00% |
| Dec. 5, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | A | Non-Qualified Stock Option (right to buy) | 18315 | $0.00 | 18,315.0000 | 136,200,000 | 9999.99% | 0.01% |
| Dec. 8, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 1699 | $712.94 | 56,437.0000 | 136,200,000 | 2.92% | 0.00% |
| Dec. 5, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | A | Common Stock | 3715 | $0.00 | 58,136.0000 | 136,200,000 | 6.83% | 0.00% |
| Oct. 30, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | G | Common Stock | 1538 | $0.00 | 54,416.0000 | 136,200,000 | 2.75% | 0.00% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | M | Common Stock | 35000 | $555.67 | 88,444.0000 | 136,200,000 | 65.49% | 0.03% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | M | Non-Qualified Stock Option (right to buy) | 35000 | $0.00 | 0.0000 | 136,200,000 | 100.00% | 0.03% |
| Oct. 29, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 32490 | $648.82 | 55,954.0000 | 136,200,000 | 36.74% | 0.02% |
| Dec. 16, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 1054 | $730.81 | 53,400.0000 | 135,300,000 | 1.94% | 0.00% |
| Dec. 6, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | A | Non-Qualified Stock Option (right to buy) | 13472 | $0.00 | 13,472.0000 | 135,300,000 | 9999.99% | 0.01% |
| Dec. 9, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 492 | $787.00 | 54,454.0000 | 135,300,000 | 0.90% | 0.00% |
| Dec. 6, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | A | Common Stock | 3499 | $0.00 | 54,946.0000 | 135,300,000 | 6.80% | 0.00% |
| Nov. 8, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | G | Common Stock | 1185 | $0.00 | 51,447.0000 | 135,300,000 | 2.25% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 1016 | $1156.43 | 53,330.0000 | 134,800,000 | 1.87% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 178 | $1157.41 | 53,152.0000 | 134,800,000 | 0.33% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 189 | $1158.78 | 52,963.0000 | 134,800,000 | 0.36% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 331 | $1159.69 | 52,632.0000 | 134,800,000 | 0.62% | 0.00% |
| Aug. 13, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | M | Non-Qualified Stock Option (right to buy) | 20000 | $0.00 | 0.0000 | 134,800,000 | 100.00% | 0.01% |
| Aug. 13, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | M | Common Stock | 20000 | $399.66 | 72,632.0000 | 134,800,000 | 38.00% | 0.01% |
| Aug. 13, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 13637 | $1141.49 | 58,995.0000 | 134,800,000 | 18.78% | 0.01% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 55 | $1140.31 | 58,940.0000 | 134,800,000 | 0.09% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 197 | $1152.36 | 56,512.0000 | 134,800,000 | 0.35% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 79 | $1143.28 | 58,813.0000 | 134,800,000 | 0.13% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 45 | $1144.89 | 58,768.0000 | 134,800,000 | 0.08% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 148 | $1145.58 | 58,620.0000 | 134,800,000 | 0.25% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 51 | $1146.60 | 58,569.0000 | 134,800,000 | 0.09% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 537 | $1148.52 | 58,032.0000 | 134,800,000 | 0.92% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 294 | $1149.60 | 57,738.0000 | 134,800,000 | 0.51% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 844 | $1150.41 | 56,894.0000 | 134,800,000 | 1.46% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 185 | $1151.46 | 56,709.0000 | 134,800,000 | 0.33% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 48 | $1142.94 | 58,892.0000 | 134,800,000 | 0.08% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 987 | $1153.74 | 55,525.0000 | 134,800,000 | 1.75% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 777 | $1154.66 | 54,748.0000 | 134,800,000 | 1.40% | 0.00% |
| Aug. 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 402 | $1155.76 | 54,346.0000 | 134,800,000 | 0.73% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 1108 | $956.34 | 54,674.0000 | 133,100,000 | 1.99% | 0.00% |
| March 13, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | M | Common Stock | 20000 | $399.66 | 72,616.0000 | 133,100,000 | 38.01% | 0.02% |
| March 13, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 14217 | $971.82 | 58,399.0000 | 133,100,000 | 19.58% | 0.01% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 182 | $951.92 | 58,217.0000 | 133,100,000 | 0.31% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 444 | $952.40 | 57,773.0000 | 133,100,000 | 0.76% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 576 | $953.77 | 57,197.0000 | 133,100,000 | 1.00% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 870 | $954.66 | 56,327.0000 | 133,100,000 | 1.52% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 545 | $955.54 | 55,782.0000 | 133,100,000 | 0.97% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 730 | $957.35 | 53,944.0000 | 133,100,000 | 1.34% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 477 | $958.34 | 53,467.0000 | 133,100,000 | 0.88% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 512 | $959.36 | 52,955.0000 | 133,100,000 | 0.96% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 47 | $961.74 | 52,908.0000 | 133,100,000 | 0.09% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 1 | $962.87 | 52,907.0000 | 133,100,000 | 0.00% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 78 | $965.51 | 52,829.0000 | 133,100,000 | 0.15% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 17 | $966.30 | 52,812.0000 | 133,100,000 | 0.03% | 0.00% |
| March 14, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 196 | $968.20 | 52,616.0000 | 133,100,000 | 0.37% | 0.00% |
| March 13, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | M | Non-Qualified Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 133,100,000 | 50.00% | 0.02% |
| Dec. 12, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 7657 | $856.71 | 52,616.0000 | 130,400,000 | 12.70% | 0.01% |
| Dec. 8, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | A | Non-Qualified Stock Option (right to buy) | 11473 | $0.00 | 11,473.0000 | 130,400,000 | 9999.99% | 0.01% |
| Dec. 11, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 669 | $844.09 | 60,273.0000 | 130,400,000 | 1.10% | 0.00% |
| Dec. 11, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 5105 | $844.09 | 60,942.0000 | 130,400,000 | 7.73% | 0.00% |
| Dec. 8, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | A | Common Stock | 3199 | $0.00 | 66,047.0000 | 130,400,000 | 5.09% | 0.00% |
| Dec. 8, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 883 | $843.79 | 62,848.0000 | 130,400,000 | 1.39% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 372 | $812.57 | 69,656.0000 | 130,400,000 | 0.53% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 167 | $813.66 | 69,489.0000 | 130,400,000 | 0.24% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 58 | $814.06 | 69,431.0000 | 130,400,000 | 0.08% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 155 | $815.97 | 69,276.0000 | 130,400,000 | 0.22% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 829 | $816.46 | 68,447.0000 | 130,400,000 | 1.20% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 1881 | $817.36 | 66,566.0000 | 130,400,000 | 2.75% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 1333 | $818.59 | 65,233.0000 | 130,400,000 | 2.00% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 973 | $819.57 | 64,260.0000 | 130,400,000 | 1.49% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 345 | $820.54 | 63,915.0000 | 130,400,000 | 0.54% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 184 | $821.46 | 63,731.0000 | 130,400,000 | 0.29% | 0.00% |
| Dec. 4, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | M | Non-Qualified Stock Option (right to buy) | 20000 | $0.00 | 0.0000 | 130,400,000 | 100.00% | 0.02% |
| Dec. 4, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | M | Common Stock | 20000 | $270.43 | 83,731.0000 | 130,400,000 | 31.38% | 0.02% |
| Dec. 4, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 13464 | $813.58 | 70,267.0000 | 130,400,000 | 16.08% | 0.01% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 136 | $810.38 | 70,131.0000 | 130,400,000 | 0.19% | 0.00% |
| Dec. 5, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 103 | $811.37 | 70,028.0000 | 130,400,000 | 0.15% | 0.00% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 347 | $795.38 | 69,124.0000 | 130,400,000 | 0.50% | 0.00% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 1614 | $798.63 | 67,306.0000 | 130,400,000 | 2.34% | 0.00% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 1601 | $799.48 | 65,705.0000 | 130,400,000 | 2.38% | 0.00% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 382 | $800.55 | 65,323.0000 | 130,400,000 | 0.58% | 0.00% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 877 | $801.56 | 64,446.0000 | 130,400,000 | 1.34% | 0.00% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 347 | $802.63 | 64,099.0000 | 130,400,000 | 0.54% | 0.00% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 330 | $803.38 | 63,769.0000 | 130,400,000 | 0.51% | 0.00% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 19 | $804.89 | 63,750.0000 | 130,400,000 | 0.03% | 0.00% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 19 | $805.00 | 63,731.0000 | 130,400,000 | 0.03% | 0.00% |
| Nov. 13, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | M | Non-Qualified Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 130,400,000 | 50.00% | 0.02% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 204 | $797.79 | 68,920.0000 | 130,400,000 | 0.30% | 0.00% |
| Nov. 13, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | M | Common Stock | 20000 | $270.43 | 83,731.0000 | 130,400,000 | 31.38% | 0.02% |
| Nov. 13, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | F | Common Stock | 13508 | $795.69 | 70,223.0000 | 130,400,000 | 16.13% | 0.01% |
| Nov. 14, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | S | Common Stock | 752 | $794.57 | 69,471.0000 | 130,400,000 | 1.07% | 0.00% |
| May 9, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | MURPHY ANDREW J | EVP Research | G | Common Stock | 1326 | $0.00 | 63,725.0000 | 130,400,000 | 2.04% | 0.00% |